Golidocitinib 1-hydroxy-2-naphthoate
Product Specifications
CAS Number
2091134-68-6 (free base)
Target
JAK
Applications
Angiogenesis
Additionnal Information
Golidocitinib 1-hydroxy-2-naphthoate is a derivative of Golidocitinib, an oral, potent, selective inhibitor of Janus kinase 1 (JAK1) with an IC50 of 70 nM. It exhibits enhnaced antitumor activity and can be used for the treatment of cancer, including peripheral T cell lymphoma (PTCL) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6311813-01 0.1 mL
JRKL, CT (JRKL, Jerky protein homolog-like, Human homolog of mouse jerky gene protein) (MaxLight 490)
Sign In for Pricing
View Details MBS6311813-02 5x 0.1 mL
JRKL, CT (JRKL, Jerky protein homolog-like, Human homolog of mouse jerky gene protein) (MaxLight 490)
Sign In for Pricing
View Details DFP02-10X1LT 10x 1 L
DMEM/F-12 ADCF DMEF with L-Glutamine and 15mM HEPES. W/O Phenol Red and Sodium Bicarbonate.
Sign In for Pricing
View Details